Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registryAngela L. Bosma, Phyllis I. Spuls, Louise A. A. Gerbens et al.|Journal of the American Academy of Dermatology|2020Cited by 58
Response to: “Comment on ‘Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry’”Angela L. Bosma, Phyllis I. Spuls, Linde E. M. de Wijs et al.|Journal of the American Academy of Dermatology|2021Cited by 0